Evaluation of first ‐line bismuth‐containing 7‐day concomitant quintuple therapy for Helicobacter pylori eradication
CONCLUSIONSBismuth‐containing 7‐day concomitant quintuple therapy may not be a superior regimen due to its unacceptable efficacy and high rate of side effects. Copyright © 2017 John Wiley & Sons, Ltd.
Source: Journal of Digestive Diseases - Category: Gastroenterology Authors: Jianfang Ye, Junbo Hong, Yin Zhu, Yong Xie, Xu Shu, Lingyu Luo, Chuan Xie, Zhenhua Zhu, Nonghua Lu Tags: Original article Source Type: research
More News: Amoxicillin | Biaxin | Clarithromycin | Esomeprazole | Gastroenterology | Helicobacter Pylori | Insomnia | Metronidazole | Nexium | Skin